Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic aquatic environmental risks from exposure to human pharmaceuticals.

Mark Crane1, Chris Watts, Tatiana Boucard

  • 1Watts and Crane Associates, 23 London Street, Faringdon, Oxfordshire, SN7 7AG, UK. mark.crane@wfcenvironment.co.uk

The Science of the Total Environment
|June 10, 2006
PubMed
Summary

Assessing chronic aquatic toxicity of human pharmaceuticals requires careful consideration of testing methods. Cyanobacteria tests show promise for unicellular organisms, while fish tests may need refinement beyond early life-stage assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.

Archives of virology·2022
Same author

Intermediate to long term results of stemless metaphyseal reverse shoulder arthroplasty: A five to nine year follow-up.

Journal of clinical orthopaedics and trauma·2021
Same author

Control performance of fish short term reproduction assays with fathead minnow (Pimephales promelas).

Regulatory toxicology and pharmacology : RTP·2019
Same author

Development of the ACTIVE framework to describe stakeholder involvement in systematic reviews.

Journal of health services research & policy·2019
Same author

Establishing the relevance of endocrine-disrupting effects for nontarget vertebrate populations.

Integrated environmental assessment and management·2019
Same author

Assessing the population relevance of endocrine-disrupting effects for nontarget vertebrates exposed to plant protection products.

Integrated environmental assessment and management·2018

Area of Science:

  • Environmental Toxicology
  • Ecotoxicology
  • Pharmaceuticals in the Environment

Background:

  • Human pharmaceuticals are increasingly detected in aquatic ecosystems.
  • Understanding their chronic toxicity is crucial for environmental risk assessment.
  • Current testing strategies for aquatic organisms need evaluation.

Purpose of the Study:

  • To review and propose optimal methods for measuring the chronic aquatic toxicity of human pharmaceuticals.
  • To identify sensitive surrogate species and appropriate testing endpoints.
  • To guide future research and regulatory approaches for pharmaceutical ecotoxicity.

Main Methods:

  • Review of existing literature on chronic aquatic toxicity testing of pharmaceuticals.
  • Evaluation of the suitability of different test organisms (Cyanobacteria, invertebrates, fish).

Related Experiment Videos

  • Assessment of the utility of biomarkers and Quantitative Structure-Activity Relationships (QSARs).

    • Main Results:

    • Cyanobacteria tests are sensitive surrogates for algae and unicellular organisms.
    • Chronic invertebrate tests may not be universally needed; more acute-to-chronic ratio data are required.
    • Chronic fish tests, potentially including full life-cycle assessments, may be necessary for specific pharmaceuticals, guided by mammalian toxicity data.
    • Biomarkers can aid in identifying active substances and receptors.
    • QSARs for chronic effects are limited by data availability.
    • Mixtures of pharmaceuticals should be assessed within a broader risk assessment framework.

    Conclusions:

    • Testing strategies for chronic pharmaceutical aquatic toxicity should be tailored to the substance and organism.
    • Cyanobacteria and refined fish tests show potential for improved assessment.
    • Further research on acute-to-chronic ratios and QSAR model development is needed.
    • A comprehensive risk assessment framework is essential for evaluating pharmaceutical mixtures in the environment.